...
首页> 外文期刊>Marine Drugs >Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
【24h】

Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411

机译:具有胰蛋白酶和胰凝乳蛋白酶抑制蓝藻Nocc edaphicum CCNP1411活性的氰肽素

获取原文

摘要

Cyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detected in the cyanobacterium Nostoc edaphicum CCNP1411 isolated from the Gulf of Gdańsk (southern Baltic Sea). Structural elucidation was performed by tandem mass spectrometry with verification by NMR for CP962 and CP985. Trypsin and chymotrypsin inhibition assays confirmed the significance of the residue adjacent to 3-amino-6-hydroxy-2-piperidone (Ahp) for the activity of the peptides. Arginine-containing CPs (CPs-Arg 2 ) inhibited trypsin at low IC 50 values (0.24–0.26 μM) and showed mild activity against chymotrypsin (IC 50 3.1–3.8 μM), while tyrosine-containing CPs (CPs-Tyr 2 ) were selectively and potently active against chymotrypsin (IC 50 0.26 μM). No degradation of the peptides was observed during the enzyme assays. Neither of the CPs were active against thrombin, elastase or protein phosphatase 1. Two CPs (CP962 and CP985) had no cytotoxic effects on MCF-7 breast cancer cells. Strong and selective activity of the new cyanopeptolin variants makes them potential candidates for the development of drugs against metabolic disorders and other diseases.
机译:氰肽素(CP)是最常见的蓝细菌肽之一,其中许多是丝氨酸蛋白酶的抑制剂。一些CP变体对水生生物,尤其是小型甲壳类也有剧毒。在这项研究中,从格但斯克湾(波罗的海南部)分离出的蓝藻Nostoc edaphicum CCNP1411中检测到13个CP,包括12个新变体。通过串联质谱进行结构阐明,并通过NMR对CP962和CP985进行验证。胰蛋白酶和胰凝乳蛋白酶抑制试验证实了与3-氨基-6-羟基-2-哌啶酮(Ahp)相邻的残基对于肽活性的重要性。含精氨酸的CPs(CPs-Arg 2)在低的IC 50值(0.24-0.26μM)下抑制胰蛋白酶,对胰凝乳蛋白酶(IC 50 3.1-3.8μM)表现出轻度的活性,而含酪氨酸的CPs(CPs-Tyr 2)具有抑制作用。对胰凝乳蛋白酶具有选择性和强效活性(IC 50 0.26μM)。在酶测定过程中未观察到肽的降解。两个CP均不具有抗凝血酶,弹性蛋白酶或蛋白质磷酸酶1的活性。两个CP(CP962和CP985)对MCF-7乳腺癌细胞无细胞毒性作用。新的氰基高岭土蛋白变体的强大且具有选择性的活性使其成为开发抗代谢异常和其他疾病药物的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号